Sitemap
Main navigation
- Health Topics
-
Grants & Funding
-
Research Training and Career Development Programs
- Family Friendly, Trainee, and Early Career Investigator Support
- Fellowship Programs: F30, F31, F32
- NIAMS Fellowship Programs: F31, F32, F30
- NIH Early-Stage Investigator (ESI) and K99 Eligibility Extension Policies
- NIH Pathway to Independence Awards: K99/ R00
- R03 Information for NIAMS K Award Recipients
- Research Career Development Awards (K awards)
- Resources from Around the NIH
- NIAMS K awards: K01, K08, K23
- Mosaic and Parent K99/R00 Information
- K99 Eligibility and Extension Information
- R03 information for NIAMS K award recipients
- NIAMS Forum for Clinical Mentored K Awardees
- The NIAMS Training Program (T32)
- ReWARD R01 Information
- Resources from Around the NIH
- NIAMS Partnership Training Initiatives
- The NIH Loan Repayment Program (LRP)
- Wellstone Muscular Dystrophy Research Network
- Clinical Trials in the Spotlight
- FAQs - CCCR
- Human Tissue and Organ Research Resource
- NIAMS R13 Conference Grant Application
- Peer Review
- Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Initiative ROAs
- SBIR/STTR FAQs
-
Supported Scientific Programs
- Frequently Asked Questions for PAR-21-055 (R01) and PAR-21-054 (R21): Mechanistic Ancillary Studies to Ongoing Clinical Projects (Clinical Trial Not Allowed)
- Orthopaedic Implant Science Program
- Orthopaedic Implant Science Program
- Orthopaedic Implant Science Program
- Arthritis Biology Program
- Cartilage and Connective Tissue Program
- Clinical Research and Diagnostic Tools for Osteoarthritis and Bone Quality
- Extracellular Matrix (ECM) Biology and Diseases Program
- Immunobiology and Immune Diseases of Skin Program
- Muscle Development and Physiology Program
- Muscle Disorders and Therapies Program
- Musculoskeletal Tissue Engineering and Regenerative Medicine Program
- Orthopaedic Research Program
- Clinical, Integrative Physiology, and Rare Diseases of Bone Program
- Rheumatic Diseases Integrative Biology Research Program
- Scleroderma, Fibrosis, and Autoinflammatory Disease Program
- Skin Repair, Regeneration, and Pigmentation
- Systemic Autoimmune Disease Biology Program
- Bone Biology, Metabolic Bone Disorders, and Osteoporosis Program
- NIAMS Current Funding Opportunities
- Applying for a Grant
- Post-Award Grants Administration
- NIH Policies and Guidance
-
Conducting Clinical Trials
- Registering with ClinicalTrials.gov
-
Clinical Trial Policies, Guidelines, and Templates
- Investigator-Initiated Clinical Research
-
Data and Safety Monitoring Guidelines and Policies
- Data and Safety Monitoring (DSM) Guidelines for Internal Safety Monitoring
- Data and Safety Monitoring (DSM) Guidelines
- Frequently Asked Questions for Investigators Conducting NIAMS-Funded Clinical Research Studies
- NIAMS Reportable Events Requirements and Guidelines for Investigators Conducting NIAMS-funded Clinical Research Studies
- Data and Safety Monitoring Boards—PI Responsibilities
- Guidelines for Reporting to a Safety Officer
- How to Write a Data and Safety Monitoring Plan
- Clinical Study Templates and Forms
- NIH and Other Federal Guidelines/Policies for Clinical Research
- NIAMS-Supported Research Programs
-
Research Training and Career Development Programs
-
Labs @ NIAMS
- Alumni
- Career Development And Outreach Branch
- Current Fellows
- FAQs - CCCR
- Faculty and Staff
- Functional Immunogenomics Unit
- NIAMS Advances
- Office of Science and Technology
- Rheumatology Fellowship Training Program
- NIAMS Labs and Core Facilities
- Clinical Care and Research
- Career Development and Outreach Branch
- Research Faculty
- Labs Grouped by Research Area
- Clinical Trials
- News Room
-
About NIAMS
- Director's Page
- NIAMS Data Science
- NIAMS Leadership
- Staff Directory
- NIAMS Budget
- NIAMS Coalition
- Working Groups and Committees
- Meetings & Events
- Partnerships
- Asian-Language Resources
- Portal en español
- FY 2024 Funding Plan
- Rheumatoid Arthritis